Estonian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
11 tulemused
Conotoxin peptides
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
SEQUENCE SUBMISSION
The present application is being filed along with a Sequence Listing in electronic format. The Sequence Listing is entitled 2323247NPSequenceListing.txt, created on 5 Oct. 2011 and is 13 kb in size. The information in the electronic format of the Sequence Listing is part of the
.alpha.O-superfamily conotoxin peptide, pharmaceutical composition and use thereof
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
TECHNICAL FIELD
The present invention pertains to fields of biochemistry and molecular biology, relates to an .alpha.O-superfamily conotoxin peptide, pharmaceutical composition, preparation method and use thereof. The present invention further relates to a propeptide of the conotoxin peptide,
Compounds and methods for kinase modulation, and indications therefor
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF THE INVENTION
Disclosed are novel compounds and uses thereof. In certain embodiments disclosed compounds are kinase inhibitors.
SUMMARY OF THE INVENTION
In certain aspects and embodiments disclosed herein, compounds are provided, as well as various salts thereof, formulations thereof,
Compounds and methods for kinase modulation, and indications therefor
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF THE INVENTION
Disclosed are novel compounds and uses thereof. In certain embodiments disclosed compounds are kinase inhibitors.
SUMMARY OF THE INVENTION
In certain aspects and embodiments disclosed herein, compounds are provided, as well as various salts thereof, formulations thereof,
Compounds and methods for kinase modulation, and indications therefor
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF THE INVENTION
Disclosed are novel compounds and uses thereof. In certain embodiments disclosed compounds are kinase inhibitors.
SUMMARY OF THE INVENTION
In certain aspects and embodiments disclosed herein, compounds are provided, as well as various salts thereof, formulations thereof,
Compounds and methods for kinase modulation, and indications therefor
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF THE INVENTION
Disclosed are novel compounds and uses thereof. In certain embodiments disclosed compounds are kinase inhibitors.
SUMMARY OF THE INVENTION
In certain aspects and embodiments disclosed herein, compounds are provided, as well as various salts thereof, formulations thereof,
High affinity human antibodies to human nerve growth factor
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF THE INVENTION
The present invention is related to human antibodies and antigen-binding fragments of human antibodies that specifically bind human nerve growth factor (NGF), and therapeutic methods of using those antibodies.
SEQUENCE LISTING
An ASCII compliant text file of the sequence
High affinity human antibodies to human nerve growth factor
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF THE INVENTION
The present invention is related to human antibodies and antigen-binding fragments of human antibodies that specifically bind human nerve growth factor (NGF), and therapeutic methods of using those antibodies.
STATEMENT OF RELATED ART
Nerve growth factor (NGF) was the first
High affinity human antibodies to human nerve growth factor
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF THE INVENTION
The present invention is related to human antibodies and antigen-binding fragments of human antibodies that specifically bind human nerve growth factor (NGF), and therapeutic methods of using those antibodies.
STATEMENT OF RELATED ART
Nerve growth factor (NGF) was the first
Compounds and methods for kinase modulation, and indications therefor
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF THE INVENTION
Disclosed are novel compounds and uses thereof. In certain embodiments disclosed compounds are kinase inhibitors.
SUMMARY OF THE INVENTION
In certain aspects and embodiments disclosed herein, compounds are provided, as well as various salts thereof, formulations thereof,
Selective modulators of the activity of the GPR55 receptor: chromenopyrazole derivatives
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF INVENTION
The present invention is in the field of pharmacology. Specifically, the present invention relates to piperazines derived from 7-methoxy-4,4-dimethyl-1,4-dihydrochromeno [4,3-c] pyrazole and 7-methoxy-4,4-dimethyl-2,4-dihydrochromene [4,3-c] pyrazole, its use for the manufacture
Kõige täiuslikum ravimtaimede andmebaas, mida toetab teadus
- Töötab 55 keeles
- Taimsed ravimid, mida toetab teadus
- Maitsetaimede äratundmine pildi järgi
- Interaktiivne GPS-kaart - märgistage ürdid asukohas (varsti)
- Lugege oma otsinguga seotud teaduspublikatsioone
- Otsige ravimtaimi nende mõju järgi
- Korraldage oma huvisid ja hoidke end kursis uudisteuuringute, kliiniliste uuringute ja patentidega
Sisestage sümptom või haigus ja lugege ravimtaimede kohta, mis võivad aidata, tippige ürdi ja vaadake haigusi ja sümptomeid, mille vastu seda kasutatakse.
* Kogu teave põhineb avaldatud teaduslikel uuringutel
